- STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and moreAn Alzheimer’s drug from Biogen slowed cognitive decline in a mid-stage trial at roughly comparable rates as approved medicinesSTAT · 13d ago↗ source
- What to know about the parasitic diarrhea outbreakFallout from the end of ACA subsidies, the FDA CBER acting director "on planet Earth," and more health news from Morning RoundsSTAT · 13d ago↗ source
- STAT+: Medicare Advantage insurers face new bipartisan scrutiny over AI and care denialsBlumenthal, Hawley press UnitedHealth, Humana, CVS for documents related to using AI to deny or delay care.STAT · 13d ago↗ source